Kathleen A Farley
12PUBLICATIONS
51CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Feb 28, 2025
Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main Protease.Jamison B Tuttle, Christophe Allais, Charlotte M N Allerton
|Feb 17, 2025
Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists.Brian S Gerstenberger, Ray Unwalla, Kathleen A Farley
|Nov 20, 2024
Cyclic Peptide C5aR1 Antagonist Design Using Solution Conformational Analysis Derived from Residual Dipolar Couplings.Kathleen A Farley, Ye Che, Ricardo Lira
|Sep 18, 2024
An Automated Purification Workflow Coupled with Material-Sparing High-Throughput 1H NMR for Parallel Medicinal Chemistry.Justin Bellenger, Martin R M Koos, Melissa Avery
|Aug 31, 2024
Structural basis for CCR6 modulation by allosteric antagonists.David Jonathan Wasilko, Brian S Gerstenberger, Kathleen A Farley
|Apr 30, 2024
A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19.Charlotte M N Allerton, Joel T Arcari, Lisa M Aschenbrenner
Pageof 2
Frequent Collaborators
3 joint publications
Matthew F Sammons
3 joint publications
Martin R M Koos
3 joint publications
Qingyi Yang
2 joint publications
Roberto R Gil
2 joint publications
Huixian Wu
2 joint publications
Stephen W Wright
2 joint publications
Christophe Allais
2 joint publications
Chulho Choi
2 joint publications
Seungil Han
2 joint publications
Matthew F Calabrese
